Back to top
more

Encompass Health (EHC)

(Real Time Quote from BATS)

$115.00 USD

115.00
1,248,348

+5.50 (5.02%)

Updated Aug 5, 2025 02:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Globus Medical (GMED) Q2 Earnings Beat Estimates, 2021 View Up

by Zacks Equity Research

Pull-through from robotics, contributions from new product introductions and resurgence in the Globus Medical's (GMED) biologics business drove second-quarter growth.

Zacks Equity Research

Cardinal Health (CAH) Q4 Earnings Lag, Revenues Top Estimates

by Zacks Equity Research

Although Cardinal Health (CAH) witnessed margin contraction in its fiscal fourth-quarter results, rise in revenues in both its segments is encouraging.

Zacks Equity Research

DENTSPLY SIRONA (XRAY) Q2 Earnings & Revenues Beat Estimates

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) second-quarter results benefit from strong segmental performance.

Zacks Equity Research

Change Healthcare (CHNG) Q1 Earnings Miss, Revenues Beat

by Zacks Equity Research

Change Healthcare's (CHNG) fiscal first-quarter results benefit from solid performance across Software and Analytics, Network Solutions and Technology-Enabled segments.

Zacks Equity Research

McKesson (MCK) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

McKesson's (MCK) fiscal first-quarter 2022 results benefit from strong performance across all segments.

Zacks Equity Research

Zacks.com featured highlights include: Encompass Health, ON Semiconductor, Kimco Realty, LKQ Corp and Saia

by Zacks Equity Research

Zacks.com featured highlights include: Encompass Health, ON Semiconductor, Kimco Realty, LKQ Corp and Saia

Zacks Equity Research

DaVita (DVA) Beats on Q2 Earnings, Raises 2021 EPS View

by Zacks Equity Research

DaVita's (DVA) strength in dialysis patient service revenues drives its Q2 top line.

Zacks Equity Research

PacBio's (PACB) Q2 Earnings Miss Estimates, Revenues Top

by Zacks Equity Research

PacBio (PACB) sees strength in Q2 product revenues, led by robust consumable sales.

Zacks Equity Research

CVS Health (CVS) Q2 Earnings Beat Estimates, EPS View Up

by Zacks Equity Research

CVS Health (CVS) Q2 adjusted EPS drops year over year on escalating costs and expenses which are putting pressure on margins.

Zacks Equity Research

Avanos Medical (AVNS) Q2 Earnings Lag Estimates, Revenues Top

by Zacks Equity Research

Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.

Zacks Equity Research

Charles River (CRL) Q2 Earnings Beat Estimates, 2021 View Up

by Zacks Equity Research

Robust performance by all three segments drove Charles River's (CRL) revenues in the second quarter.

Swayta Shah headshot

5 Best Stocks With Upgraded Broker Ratings Worth Investing In

by Swayta Shah

By following broker ratings upgrades, you can easily find attractive and profitable stocks. So, we choose Encompass Health (EHC), ON Semiconductor (ON), Kimco Realty (KIM), LKQ Corporation (LKQ) and Saia (SAIA) as these have witnessed ratings upgrade.

Zacks Equity Research

AmerisourceBergen (ABC) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth.

Zacks Equity Research

Myriad Genetics (MYGN) Q2 Earnings Beat, Gross Margin Rises

by Zacks Equity Research

Strength in Myriad Genetics' (MYGN) Molecular Diagnostic segment has managed to drive Q2 sales despite a challenging business environment.

Zacks Equity Research

Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Expand

by Zacks Equity Research

Zimmer Biomet (ZBH) sales improve across all its operating segments and geographies on recovery from the pandemic in the months of the second quarter.

Zacks Equity Research

Henry Schein (HSIC) Q2 Earnings Top Estimates, 2021 EPS View Up

by Zacks Equity Research

Strengthening demand in the global dental and medical markets drove Henry Schein's (HSIC) revenues in the second quarter.

Zacks Equity Research

Bruker (BRKR) Q2 Earnings Beat Estimates, 2021 Guidance Up

by Zacks Equity Research

Bruker (BRKR) reports better-than-expected revenues for the second quarter of 2021 on strong segmental performance driving the top line.

Zacks Equity Research

Encompass Health (EHC) Beats on Q2 Earnings, Hikes '21 View

by Zacks Equity Research

Encompass Health's (EHC) second-quarter results highlight growing revenues stemming from strong segmental performances, partly offset by elevated costs.

Zacks Equity Research

Zacks.com featured highlights include: Encompass Health, Celanese Corp, Salesforce, Ovintiv and Expeditors International of Washington

by Zacks Equity Research

Zacks.com featured highlights include: Encompass Health, Celanese Corp, Salesforce, Ovintiv and Expeditors International of Washington

Zacks Equity Research

Encompass Health (EHC) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 15.84% and 1.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ecolab (ECL) Q2 Earnings & Revenues Beat Mark, Margins Rise

by Zacks Equity Research

Ecolab's (ECL) robust performances across majority of its segments drive its Q2 sales despite pandemic-led business challenges.

Zacks Equity Research

PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

PerkinElmer's (PKI) second-quarter results benefit from strong segmental performance.

Swayta Shah headshot

5 Top Stocks With Impressive Sales Growth to Buy Right Away

by Swayta Shah

Sales growth is important for the survival of any business. Let's check Encompass Health (EHC), Celanese (CE), salesforce.com (CRM), Ovintiv (OVV) & Expeditors International (EXPD) that are likely to witness solid top-line growth.

Zacks Equity Research

EHC or AMED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

EHC vs. AMED: Which Stock Is the Better Value Option?

Zacks Equity Research

Is a Surprise Coming for Encompass Health (EHC) This Earnings Season?

by Zacks Equity Research

Encompass Health (EHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.